Clearside Biomedical Statistics

Total Valuation

CLSD has a market cap or net worth of $76.99 million. The enterprise value is $95.22 million.

Market Cap	76.99M
Enterprise Value	95.22M

Important Dates

The next confirmed earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CLSD has 74.75 million shares outstanding. The number of shares has increased by 10.50% in one year.

Shares Outstanding	74.75M
Shares Change (YoY)	+10.50%
Shares Change (QoQ)	+6.98%
Owned by Insiders (%)	7.47%
Owned by Institutions (%)	23.03%
Float	69.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.21
Forward PS	169.48
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	12.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.07

Current Ratio	5.07
Quick Ratio	5.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.67

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-44.05%
Return on Capital (ROIC)	-60.12%
Revenue Per Employee	$250,800
Profits Per Employee	-$1.12M
Employee Count	30
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.84% in the last 52 weeks. The beta is 2.33, so CLSD's price volatility has been higher than the market average.

Beta (5Y)	2.33
52-Week Price Change	+7.84%
50-Day Moving Average	1.17
200-Day Moving Average	1.27
Relative Strength Index (RSI)	39.84
Average Volume (20 Days)	1,586,696

Short Selling Information

The latest short interest is 1.95 million, so 2.61% of the outstanding shares have been sold short.

Short Interest	1.95M
Short Previous Month	261,216
Short % of Shares Out	2.61%
Short % of Float	2.82%
Short Ratio (days to cover)	1.39

Income Statement

In the last 12 months, CLSD had revenue of $7.52 million and -$33.46 million in losses. Loss per share was -$0.50.

Revenue	7.52M
Gross Profit	7.38M
Operating Income	-25.77M
Pretax Income	-34.97M
Net Income	-33.46M
EBITDA	-25.66M
EBIT	-25.77M
Loss Per Share	-$0.50

Full Income Statement

Balance Sheet

The company has $29.36 million in cash and $47.59 million in debt, giving a net cash position of -$18.23 million or -$0.24 per share.

Cash & Cash Equivalents	29.36M
Total Debt	47.59M
Net Cash	-18.23M
Net Cash Per Share	-$0.24
Equity (Book Value)	-28.29M
Book Value Per Share	-0.38
Working Capital	23.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.11 million and capital expenditures -$1.05 million, giving a free cash flow of -$20.16 million.

Operating Cash Flow	-19.11M
Capital Expenditures	-1.05M
Free Cash Flow	-20.16M
FCF Per Share	-$0.27

Full Cash Flow Statement

Margins

Gross Margin	98.11%
Operating Margin	-342.48%
Pretax Margin	-444.66%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-242.42%

Dividends & Yields

CLSD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.50%
Shareholder Yield	-10.50%
Earnings Yield	-43.46%
FCF Yield	-26.18%

Analyst Forecast

The average price target for CLSD is $5.17, which is 401.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.17
Price Target Difference	401.94%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	77.65%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CLSD has an Altman Z-Score of -14.71 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-14.71
Piotroski F-Score	3